Category Archives: Global Health

UK Parliamentarians Call Attention to Neglected Tropical Diseases During Recent Debates

uk-parliament

This blog post was originally published on the Sabin Vaccine Institute website.  

Earlier this month the United Kingdom’s Houses of Parliament met on two separate occasions to discuss global health priorities  with debates on global health research and development and health systems strengthening. These debates occurred at a crucial time in the Parliament’s calendar as the UK draws closer to the end of this parliamentary session (2010 – 2015) and moves forward towards the General Election in May 2015. It is one of the last few opportunities for parliamentarians to raise awareness of key global health issues before a new Government and parliament is voted in during the spring of 2015.

Baroness Helene Hayman, Board Trustee at the Sabin Vaccine Institute and Vice-chair of the UK’s All- Party Parliamentary Group on Malaria and Neglected Tropical Diseases (NTDs); and Jeremy Lefroy, Member of Parliament (MP) and Board Trustee for Sabin Foundation Europe, raised important points on the role of NTD control and elimination in alleviating poverty and needless suffering in these parliamentary discussions, highlighting successes to date and the challenges that lie ahead.

On Monday December 8th, following the release of the All-Party Parliamentary Group on Global Tuberculosis report on Global Health Research and Development, the UK parliament’s House of Lords hosted a debate on research and development for tuberculosis, and the UK’s broader global health research agenda.

Baroness Hayman began by congratulating the All-Party Parliamentary Group on Global TB on their recent report titled, Dying for a Cure: Research and Development in Global Health. She applauded the report’s recognition of the 1.4 billion people who suffer from NTDs and called for increased research for new tools to combat these diseases, highlighting the significant impact of vaccines in combating these diseases.

“[The report] has recognized that NTDs are diseases not only born of poverty but which create poverty,” she said. “They undermine education, employment, health—all the opportunities that would allow people to claw their way out of poverty. Therefore, combating the diseases of the poor, including the big three (HIV/AIDS, tuberculosis and malaria), is an essential element of the fight against poverty and for social and economic development.”

“For some of those diseases, we already have treatments for which we need more resources — for example, for mass drug administration for soil-borne helminth diseases,” argued Baroness Hayman. “But we still desperately need to develop better medicines, smarter diagnostics and, above all, vaccines if we are to make progress.”

Given the success of investments (including from the UK Government) in to product development partnerships (PDPs) such as Drugs for Neglected Diseases initiative and PATH, in producing a number of new tools to combat diseases as well as filling a robust pipeline of candidates for clinical trials in recent years, Baroness Hayman called on the Department for International Development (DFID) to not only increase its budget to further support global health research and development (R&D) but also that continued support and greater investment be directed to  PDPs. PDPs, an innovative model of research that combines private, public and philanthropic partnerships to help develop and progress research candidates in the most efficient way possible, have proven themselves to be an excellent R&D model that is channeling results from investments.

Baroness Hayman also recognized that new tools for NTDs will play a vital role alongside the scale up of delivery of existing NTD treatments to help us achieve global goals in control and elimination of these diseases.

Baroness Hayman ended her comments with two final pleas to the UK Government. The first, to increase their commitment, and the resources they devote, to the “vital work of PDPs.” The second, “to not neglect the importance of the research that can take place in the countries and the communities where diseases are themselves endemic,” commenting on the importance of investing in capacity strengthening of scientists in countries with a high burden of these diseases.

On December 11th, two days after the House of Lords debate, the House of Commons convened for an additional debate following the final reports of the International Development Select Committee (IDC) inquiries on Health Systems Strengthening and Disability. Jeremy Lefroy MP, urged Parliament and the UK Government to continue to prioritize NTD efforts in the areas of health systems strengthening and disability.

In his comments, Jeremy Lefroy references the importance of integrated disease programs in Tanzania which have helped maximize the efficiency of health systems.

“This programme tackles neglected tropical diseases,” he explained. “Instead of looking at only one—lymphatic filariasis, for instance, or worms—it is tackling four of those debilitating diseases alongside each other.

In other parts of the world we find the use of pooled funds—for example, pooled health funds in South Sudan and Mozambique, the development partners for health in Kenya and the health transition fund in Zimbabwe. All are excellent examples of people coming together to strengthen health systems locally, showing that it is not simply about one person making their one vertical intervention, but everyone working to bring the money together and make the best use of it.”

Jeremy Lefroy also emphasized the importance of prevention for controlling and eliminating NTDs and malaria.

“[NTDs] affect the poorest people on this planet—something like 1.4 billion people in the course of a year.” He said. “In fact, NTDs not only affect the poorest people and cause morbidity and sometimes mortality, but they often cause disability. And they are eminently curable, or at least eminently preventable, often by very cheap interventions.

That is why I was thrilled that the last Government decided to make NTDs a priority, and this Government, through the London declaration on NTDs in January 2012, has continued that work, providing, I think, £240 million in total, including the money committed by the last Government, over a four-year period. I ask the Minister to ensure that that commitment to the prevention and treatment of NTDs is continued, because it has a huge impact on disability and the prevention of disability.”

As we draw closer to the end of the current set of Millennium Development Goal and global discussions on what happens next through the Post 2015 development agenda, these parliamentary discussions on global health issues in many countries, including those like the UK who are key champions for NTDs, will play a critical role in building the essential political will to increase efforts to reach global NTD goals. We hope that these discussions will also continue in other countries to stimulate further global discussion on recognizing the milestone achievements we have reached so far as well as what more must be done to end these diseases for once and for all.

To read the full transcript of the House of Lords debate, click here. To read the full transcript of the House of Commons debate, click here.

Continue reading

Health for All. Everywhere.

 

UHC

This blog post was originally published on the Sabin Vaccine Institute website. 

This month, Sabin Vaccine Institute joined over 260 organizations to support the launch of the first-ever Universal Health Coverage DayWith a tagline of “Health for All. Everywhere,” Universal Health Coverage Day, taking place on December 12, will call for universal health coverage (UHC) to be a global priority.

The push for UHC began two years ago on December 12th, when the United Nations General Assembly unanimously adopted a landmark resolution endorsing UHC as a global priority for sustainable development. The resolution urged governments to scale up efforts to accelerate the transition towards UHC.

It is estimated that over 1 billion people lack basic health care and 100 million fall into poverty every year trying to access it. Nearly a third of households in Africa and Southeast Asia have to borrow money or sell assists to pay for health care. The lack of affordable, quality healthcare leaves families and nations impoverished.

As the post 2015 development agenda takes shape, key health partners such as The World Health Organization (WHO) and the World Bank Group have already developed a framework for countries to measure UHC progress, demonstrating that UHC is an indicator that can be measured at a national and global level.

Sabin is happy to join organizations around the world this Universal Health Coverage Day. We believe in making essential health interventions—such as cost-effective vaccines and treatment for neglected tropical diseases (NTDs)—accessible to those that cannot afford or access them, as well as supporting the global vision of providing UHC for all impoverished and vulnerable populations.

You can learn more about Universal Health Coverage Day here.

Blog Action Day: Standing up for the World’s Poor

 

SLE12.0713.SABIN0222

END7 is participating in Blog Action Day on October 16th — a day for thousands of bloggers to come together to talk about inequality. 

Most people living in the United States and other high-income countries have never heard of diseases like elephantiasisriver blindnesssnail fevertrachomaroundworm, whipworm or hookworm. But nearly one in six people globally, including more than half a billion children, have these diseases – known as neglected tropical diseases (NTDs). Without treatment, NTDs can lead to lifelong disabilities and suffering. Because NTDs largely affect the world’s most vulnerable communities, those already affected by extreme poverty, they are notorious for perpetuating inequality.

Yet ending NTDs is an achievable and realistic goal. All it takes is 50 cents per person per year to treat and protect someone from all seven of the most common NTDs. And with regular treatment, NTDs can be controlled and eliminated for good.

NTDs have devastating consequences for the world’s poorest people. They can lead to malnutrition and stunting, blindness, disfiguration, cognitive delays, lost productivity, poor maternal and child health and social stigmatization.

The links between NTDs and inequality are well documented. For example, an article published in PLOS NTDs revealed that Indonesia’s high prevalence of NTDs could perpetuate inequality within the country, despite its surging economy. NTDs make it hard for parents to make a living, and for children to attend school. These diseases drastically weaken a person’s health and cause unnecessary suffering.

When children and parents become infected with one or more NTD, their potential is diminished; five-year-old Neema was unable to attend school because of intestinal worms – a type of NTD. And Sahr Gando, a father in Sierra Leone, could no longer work and provide for his family when he became infected with schistosomiasis, a painful NTD that can lead to death.

Countries like Colombia and Ecuador have already eliminated the NTD onchocerciasis. And countless other countries in Africa, Asia and Latin America are well on their way to ending needless suffering caused by NTDs.

By defeating NTDs, we can ensure that the world’s poor have an equal chance. At the basic level, everyone should have adequate nutrition, the opportunity to be educated and the right to prosper and contribute to society. Yet NTDs rob the billion and a half people living in poverty of these basic opportunities and undermine other development efforts. If we wish to end inequality, we must end NTDs. If we wish to address some of the world’s greatest challenges like world hunger, AIDS, poverty and needless suffering, we must end NTDs.

But in order to end NTDs and achieve greater health equity, we must continue to raise awareness and advocate for the control and elimination of these diseases. Ending NTDs must be a priority within the global development agenda and among world leaders. Countries like the United States and the United Kingdom must remain committed, and even increase their commitments, to supporting NTD-endemic countries in their fight against NTDs. Most of all, we cannot remain quiet and take a back seat as more than half a million children continue to suffer from preventable diseases. Stand up against inequality today by pledging to end NTDs.

When the Right to Health Becomes a Battle for Recognition & Dignity

 

C

The following post is an opinion piece from Jeanne Chauffour, a student at the University of Chicago*

Health is a human right. This phrase is clearly stated in Article 25 of the Universal Declaration of Human Rights (1948), along with a long list of other highly-held treaties and conventions. For countries having ratified these treaties, the right to health should be strongly defended. Unfortunately, health is still a commodity or unattainable luxury for millions of people around the world – both in developed and developing nations.

Longstanding efforts certainly exist to remedy the great health inequalities of our time; millions of dollars a year are donated to large organizations, agencies, and bodies who strive to improve health and wellbeing in the most impoverished settings across the world. And for the most part, they have done good work – we have reduced maternal mortality rates, and the AIDS-free generation is a tangible reality. Yet, one health issue that continues to be underfunded and underprioritzed is neglected tropical diseases, or NTDs.

Health is a human right. And NTDs are a serious health concern. There are seventeen NTDs that currently plague our planet –, seven of which represent 90 percent of the global burden. NTDs are the most common affliction among the world’s poorest people, but they are often ignored because they mostly infect those living in rural poverty. The individuals infected with NTDs are rarely the focus of media attention.

NTDs have been referred to as “the forgotten disease of the forgotten people,” causing disfigurement (swollen abdomens and limbs), rashes, and inverted eyelashes, and fueling stigma — making it harder for those affected to break the cycle of poverty. NTDs can also lead to long-term disabilities and other health issues such as blindness. In many cultures, the condition of those suffering from NTDs is perceived to be a curse or a sin, and the stigma can affect an entire family. I cannot even come close to imagining the life and mental health conditions of the millions of people worldwide living with NTDs.

NTDs can also cause stunted growth and malnutrition. In addition, NTDs are directly correlated to the first six Millennium Development Goals, or MDGs, that have guided our international development efforts over the past fourteen years. Our failure to adequately address the NTD burden may have contributed to our failure to reach many of the MDGs, which will be replaced by new UN goals later this year.

The unfortunate truth is that some diseases that affect western communities (such as cancer, diabetes or HIV/AIDS) are propelled to the forefront of research, while other treatable diseases not found in the developed world receive less attention and funding. NTDs have been around for hundreds of years, and some of their treatments are decades old, yet they lag behind other conditions in the attention they receive from the global community.

Luckily, a solution exists, and recent efforts have raised the visibility of NTDs on the global health agenda. On January 30, 2012, the London Declaration on NTDs was signed by the WHO, the World Bank, the Gates Foundation, thirteen pharmaceutical companies, and leaders from the US, UK and UAE. These stakeholders committed to ensuring the resources necessary to end the public health threat of ten of the most common NTDs by 2020, and progress since has been impressive.

Even more, some countries have been successful in eradicating or eliminating NTDs over the past few years: Oman has eliminated trachoma, Colombia has eliminated onchocerciasis, and Nigeria eradicated guinea worm disease. In all, over 70 countries have developed multi-year integrated NTD plans, and the World Health Assembly (WHA) adopted a landmark resolution on all 17 NTDs in May 2013.

The London Declaration has been a huge step forward in solidifying the commitment of pharmaceutical companies to donate the medicine needed to protect a person from the seven most common NTDs for one whole year. National governments coordinate the distribution of the medicine with local health workers who administer the medicine during annual mass drug administrations (MDAs). But a large funding gap persists that limits our efforts to scale up treatment to everyone who needs it.

Health is a human right. And so are many other things: free speech, choice of religion, participation in civic and political life and education. Yet, health is and should be perceived as one of the fundamental rights humans have, without which the exercise of their other rights and freedoms is limited or nonexistent. Health more than any other factor determines livelihood and the capacity to improve one’s own condition.

Health is the driving mechanism to generate wealth, access, and success in many other types of activities – being able to vote, being able to go to school, contributing to the progress and growth of your country’s economy, being able to choose a respectful partner and have healthy children of your own.

Health is a human right, and any phrase related to health with the word “neglected” in its title must find justice, especially when we are equipped with all the tools that we need to succeed. It is only when these basic health inequities will be solved that our world will truly be able to pull the most and the best from individuals’ potential. Health is a human right.

 *Jeanne Chauffour is a rising fourth year undergraduate student at The University of Chicago where she studies in the History, Philosophy, and Social Studies of Science and Medicine (HIPSS) and Human Rights departments. Jeanne is the 2014-2015 Internal Co-President at GlobeMed at the University of Chicago, a student global health non-profit organization she has been a part of since her freshman year. Jeanne is also involved in community health with Students for Health Equity, the Student Health Advisory Board, the University of Chicago Center for Global Health, and Ci3. In October 2014, Jeanne will be a delegate at the Millennium Campus Conference.